Clinical Trial

Thalidomide Therapy for VEOIBD

Recruiting
View on ClinicalTrials.gov →
Record status
This record was last updated May 22, 2025 (before its estimated December 31, 2025 completion). Its status may not reflect the trial's current state.
Summary
This is a single center, observational study to investigate the clinical outcomes of thalidomide treatment for very early onset inflammatory bowel disease
Protocol Amendment History 2 amendments
This ClinicalTrials.gov record has been amended 2 times since 2024-04-21; most recent amendment 2025-05-19.
Status change: Not Yet Recruiting → Recruiting 2024-07-01
Trial Details
NCT Number NCT06382519
Lead Sponsor Children's Hospital of Fudan University
Conditions Inflammatory Bowel Diseases
Enrollment 40 participants
Start Date 2024-05-15
Primary Completion 2025-12-31 (estimated)
Study Completion 2026-12-31 (estimated)
Updated on ClinicalTrials.gov 2025-05-22